614 related articles for article (PubMed ID: 26320066)
1. Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.
Feldman SA; Assadipour Y; Kriley I; Goff SL; Rosenberg SA
Semin Oncol; 2015 Aug; 42(4):626-39. PubMed ID: 26320066
[No Abstract] [Full Text] [Related]
2. Improving the efficacy and safety of engineered T cell therapy for cancer.
Shi H; Liu L; Wang Z
Cancer Lett; 2013 Jan; 328(2):191-7. PubMed ID: 23022475
[TBL] [Abstract][Full Text] [Related]
3. CAR T Cell Therapy for Solid Tumors.
Newick K; O'Brien S; Moon E; Albelda SM
Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
[TBL] [Abstract][Full Text] [Related]
4. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
Houot R; Schultz LM; Marabelle A; Kohrt H
Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
[TBL] [Abstract][Full Text] [Related]
5. Adoptive CD8
Jiang X; Xu J; Liu M; Xing H; Wang Z; Huang L; Mellor AL; Wang W; Wu S
Cancer Lett; 2019 Oct; 462():23-32. PubMed ID: 31356845
[TBL] [Abstract][Full Text] [Related]
6. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
Ikeda H
Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the toxicity hurdles of genetically targeted T cells.
Casucci M; Hawkins RE; Dotti G; Bondanza A
Cancer Immunol Immunother; 2015 Jan; 64(1):123-30. PubMed ID: 25488419
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy using tumor antigen-reactive T cells.
Choi BK; Kim SH; Kim YH; Kwon BS
Immunotherapy; 2018 Mar; 10(3):235-245. PubMed ID: 29370726
[TBL] [Abstract][Full Text] [Related]
9. Cellular immunotherapy for malignant gliomas.
Lin Y; Okada H
Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
[TBL] [Abstract][Full Text] [Related]
10. Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy.
Schlenker R; Olguín-Contreras LF; Leisegang M; Schnappinger J; Disovic A; Rühland S; Nelson PJ; Leonhardt H; Harz H; Wilde S; Schendel DJ; Uckert W; Willimsky G; Noessner E
Cancer Res; 2017 Jul; 77(13):3577-3590. PubMed ID: 28533272
[TBL] [Abstract][Full Text] [Related]
11. Adoptive T cell therapy: points to consider.
Yee C
Curr Opin Immunol; 2018 Apr; 51():197-203. PubMed ID: 29730057
[TBL] [Abstract][Full Text] [Related]
12. Adoptive cell therapy: past, present and future.
Cohen JE; Merims S; Frank S; Engelstein R; Peretz T; Lotem M
Immunotherapy; 2017 Jan; 9(2):183-196. PubMed ID: 28128715
[TBL] [Abstract][Full Text] [Related]
13. Redirected T cells in cancer therapy.
Sangiolo D
Expert Opin Biol Ther; 2015; 15(12):1667-70. PubMed ID: 26515608
[TBL] [Abstract][Full Text] [Related]
14. From CARs to TRUCKs and Beyond: Safely en Route to Adoptive T-cell Therapy for Cancer.
Dummy
EBioMedicine; 2016 Dec; 14():1-2. PubMed ID: 27986279
[No Abstract] [Full Text] [Related]
15. The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy.
Foster JB; Barrett DM; Karikó K
Mol Ther; 2019 Apr; 27(4):747-756. PubMed ID: 30819612
[TBL] [Abstract][Full Text] [Related]
16. [T cell-based immunotherapies in solid tumors].
Baulu E; Dougé A; Chuvin N; Bay JO; Depil S
Bull Cancer; 2021 Oct; 108(10S):S96-S108. PubMed ID: 34920813
[TBL] [Abstract][Full Text] [Related]
17. Adoptive T cell therapy: Boosting the immune system to fight cancer.
Leon E; Ranganathan R; Savoldo B
Semin Immunol; 2020 Jun; 49():101437. PubMed ID: 33262066
[TBL] [Abstract][Full Text] [Related]
18. Is antigen specificity the key to efficient adoptive T-cell therapy?
Labarriere N; Khammari A; Lang F; Dreno B
Immunotherapy; 2011 Apr; 3(4):495-505. PubMed ID: 21463191
[TBL] [Abstract][Full Text] [Related]
19. TCR Gene Therapy: Challenges, Opportunities, and Future Directions.
Stauss HJ; Tran MGB
Cells; 2020 Dec; 9(12):. PubMed ID: 33271744
[TBL] [Abstract][Full Text] [Related]
20. Cellular Therapy and Cytokine Treatments for Melanoma.
Borgers JSW; Haanen JBAG
Hematol Oncol Clin North Am; 2021 Feb; 35(1):129-144. PubMed ID: 33759770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
